Jci_page_head_homepage_01 Jci_page_head_homepage_02
Norbert Frey, Derk Frank, Stefanie Lippl, Christian Kuhn, Harald Kögler, Tomasa Barrientos, Claudia Rohr, Rainer Will, Oliver J. Müller, Hartmut Weiler, Rhonda Bassel-Duby, Hugo A. Katus, Eric N. Olson
Published in Volume 118, Issue 11
J Clin Invest. 2008; 118(11):3598–3608 doi:10.1172/JCI36277
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Jci0836277
Figure 9
Schematic model depicting calsarcin-2 inhibition of calcineurin activity.

In WT skeletal muscle, calsarcin-2 is localized to the Z-disc and inhibits calcineurin activity. Phosphorylated NFAT remains in the cytoplasm. In Myoz1 KO skeletal muscle, calcineurin dephosphorylates NFAT with consequent nuclear translocation and activation of the calcium-dependent gene program.